Two global drug manufacturers, Pfizer and Cipla, have signed a deal that will see Kenyans buy a range of up to 16 cancer drugs at half the market price.
The partnership is backed by the American Cancer Society (ACS) and Clinton Health Access Initiative (CHAI).
